Perspective: Metabotyping-A Potential Personalized Nutrition Strategy for Precision Prevention of Cardiometabolic Disease
- PMID: 31782487
- PMCID: PMC7231594
- DOI: 10.1093/advances/nmz121
Perspective: Metabotyping-A Potential Personalized Nutrition Strategy for Precision Prevention of Cardiometabolic Disease
Abstract
Diet is an important, modifiable lifestyle factor of cardiometabolic disease risk, and an improved diet can delay or even prevent the onset of disease. Recent evidence suggests that individuals could benefit from diets adapted to their genotype and phenotype: that is, personalized nutrition. A novel strategy is to tailor diets for groups of individuals according to their metabolic phenotypes (metabotypes). Randomized controlled trials evaluating metabotype-specific responses and nonresponses are urgently needed to bridge the current gap of knowledge with regard to the efficacy of personalized strategies in nutrition. In this Perspective, we discuss the concept of metabotyping, review the current literature on metabotyping in the context of cardiometabolic disease prevention, and suggest potential strategies for metabotype-based nutritional advice for future work. We also discuss potential determinants of metabotypes, including gut microbiota, and highlight the use of metabolomics to define effective markers for cardiometabolic disease-related metabotypes. Moreover, we hypothesize that people at high risk for cardiometabolic diseases have distinct metabotypes and that individuals grouped into specific metabotypes may respond differently to the same diet, which is being tested in a project of the Joint Programming Initiative: A Healthy Diet for a Healthy Life.
Keywords: cardiometabolic diseases; gut microbiota; metabolomics; metabotyping; personalized nutrition; precision nutrition; targeted nutrition.
Copyright © The Author(s) 2019.
Figures


Similar articles
-
Metabotyping and its role in nutrition research.Nutr Res Rev. 2020 Jun;33(1):33-42. doi: 10.1017/S0954422419000179. Epub 2019 Aug 22. Nutr Res Rev. 2020. PMID: 31434587 Review.
-
Metabotyping and its application in targeted nutrition: an overview.Br J Nutr. 2017 Jun;117(12):1631-1644. doi: 10.1017/S0007114517001611. Epub 2017 Jul 19. Br J Nutr. 2017. PMID: 28720150 Review.
-
Metabolic phenotyping in people living with obesity: Implications for dietary prevention.Rev Endocr Metab Disord. 2023 Oct;24(5):825-838. doi: 10.1007/s11154-023-09830-4. Epub 2023 Aug 15. Rev Endocr Metab Disord. 2023. PMID: 37581871 Free PMC article. Review.
-
Metabotyping: a tool for identifying subgroups for tailored nutrition advice.Proc Nutr Soc. 2023 May;82(2):130-141. doi: 10.1017/S0029665123000058. Epub 2023 Feb 2. Proc Nutr Soc. 2023. PMID: 36727494 Free PMC article. Review.
-
[Metabolic phenotyping in the development personalized nutrition].Postepy Biochem. 2020 Jun 27;66(2):125-133. doi: 10.18388/pb.2020_329. Postepy Biochem. 2020. PMID: 32700505 Review. Polish.
Cited by
-
Three-Dimensional Printing of Foods: A Critical Review of the Present State in Healthcare Applications, and Potential Risks and Benefits.Foods. 2023 Sep 1;12(17):3287. doi: 10.3390/foods12173287. Foods. 2023. PMID: 37685220 Free PMC article. Review.
-
The Effect of Inflammation and Insulin Resistance on Lipid and Lipoprotein Responsiveness to Dietary Intervention.Curr Dev Nutr. 2020 Oct 15;4(11):nzaa160. doi: 10.1093/cdn/nzaa160. eCollection 2020 Nov. Curr Dev Nutr. 2020. PMID: 33447695 Free PMC article.
-
Exploration of differential responses to FODMAPs and gluten in people with irritable bowel syndrome- a double-blind randomized cross-over challenge study.Metabolomics. 2024 Feb 12;20(2):21. doi: 10.1007/s11306-023-02083-x. Metabolomics. 2024. PMID: 38347192 Free PMC article. Clinical Trial.
-
Future prospects for dissecting inter-individual variability in the absorption, distribution and elimination of plant bioactives of relevance for cardiometabolic endpoints.Eur J Nutr. 2019 Nov;58(Suppl 2):21-36. doi: 10.1007/s00394-019-02095-1. Epub 2019 Oct 23. Eur J Nutr. 2019. PMID: 31642982 Free PMC article. Review.
-
Optimized Metabotype Definition Based on a Limited Number of Standard Clinical Parameters in the Population-Based KORA Study.Life (Basel). 2022 Sep 20;12(10):1460. doi: 10.3390/life12101460. Life (Basel). 2022. PMID: 36294895 Free PMC article.
References
-
- World Health Organization. Diet, nutrition and the prevention of chronic diseases: Report of a Joint WHO/FAO Expert Consultation, Geneva, 28 January – 1 February 2002. Geneva, Switzerland: World Health Organization; 2002.
-
- Maiani G, Caston MJ, Catasta G, Toti E, Cambrodon IG, Bysted A, Granado-Lorencio F, Olmedilla-Alonso B, Knuthsen P, Valoti M. Carotenoids: Actual knowledge on food sources, intakes, stability and bioavailability and their protective role in humans. Mol Nutr Food Res. 2009;53(Suppl 2):S194–218. - PubMed
-
- Walton J, Kehoe L, McNulty BA, Nugent AP, Flynn A. Nutrient intakes and compliance with nutrient recommendations in children aged 1–4 years in Ireland. J Hum Nutr Diet. 2017;30:665–76. - PubMed